FindTrial
Sign In

Prophylactic DLI

BIOLOGICAL2 trials

Sponsors

Chinese PLA General Hospital, Peking University People's Hospital

Conditions

Acute Myeloid LeukemiaDecitabineDonor Lymphocyte InfusionGraft-versus-host DiseaseMyelodysplastic Syndromes (MDS)Peripheral Blood Stem Cell TransplantationRelapse

Phase 2

Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies
NCT03771222
Chinese PLA General HospitalDecitabine, Donor Lymphocyte Infusion, Graft-versus-host Disease +2
Start: 2019-01-31End: 2021-12-31Target: 40Updated: 2018-12-13

Unknown Phase

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT
Not yet recruitingNCT07319793
Peking University People's HospitalAcute Myeloid Leukemia, Myelodysplastic Syndromes (MDS)
Start: 2026-01-01End: 2028-06-30Target: 200Updated: 2026-01-06